Biomarker for Alport Syndrome (BioAlport)

Clinical trial NCT02718027 · TERMINATED

Trial details

NCT number: NCT02718027
Sponsor: CENTOGENE GmbH Rostock
Status: TERMINATED
Study type: OBSERVATIONAL

Nephritis, Hereditary Hematuria-Nephropathy-Deafness Syndrome

Start date: 2018-08-20
Primary completion: 2022-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.